Cargando…
Pharmacogenetic typing for oral anti-coagulant response among factor V Leiden mutation carriers
CONTEXT: Factor V Leiden mutation is the most common inherited predisposition for hypercoagulability and thereby a common genetic cause for initiation of oral anti-coagulation therapy. There is a dearth of knowledge of coumarin response profile in such thrombophilic population. AIMS: The current pil...
Autores principales: | Nahar, Risha, Saxena, Renu, Deb, Roumi, Verma, Ishwar C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656522/ https://www.ncbi.nlm.nih.gov/pubmed/23716941 http://dx.doi.org/10.4103/0971-6866.107987 |
Ejemplares similares
-
Molecular studies of achondroplasia
por: Nahar, Risha, et al.
Publicado: (2009) -
The Association of Coagulation Factor V (Leiden) and Factor II (Prothrombin) Mutations With Stroke
por: Pirhoushiaran, Maryam, et al.
Publicado: (2014) -
SV-IV Peptide1–16 reduces coagulant power in normal Factor V and Factor V Leiden
por: Di Micco, Biagio, et al.
Publicado: (2007) -
Myotonic Dystrophy-1 Complicated by Factor-V (Leiden) Mutation
por: Finsterer, Josef, et al.
Publicado: (2015) -
Combination of factor V Leiden and MTHFR mutations in myocardial infarction
por: Fekih-Mrissa, Najiba, et al.
Publicado: (2013)